(EXEL:Consolidated Issue Listed on NASDAQ Global Select )
Michael M. Morrissey Ph.D.
Chief Executive Officer, President and Director, Exelixis, Inc.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 2 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Michael M. Morrissey, Ph.D. has been the Chief Executive Officer and President at Exelixis, Inc., since July 2010. Dr. Morrissey served as the President of Research and Development at Exelixis Inc., since January 4, 2007. Dr. Morrissey served as an Executive Vice President of Discovery of Exelixis Inc., from January 2006 to December 2006 and its Senior Vice President of Discovery Research from January 2003 to December 2005. Dr. Morrissey served as Vice President ...
210 East Grand AvenuePhone: 650-837-7000
South San Francisco, California 94080
Board Members Memberships*
Chief Executive Officer, President and Director
Concordia University, Wisconsin
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Ali Fattaey Ph.D.||Chief Executive Officer, President and Director|
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|Raul R. Rodriguez||Chief Executive Officer, President, Director and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|€459.0K||Compensation as of Fiscal Year 2013.|